SAHA SAURABH (CIK 1861926) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-15). Recent activity: Sell CLVT (8,178 shares), Buy CLVT (62,264 shares), Buy CNTA (55,000 shares), Sell CNTA (55,000 shares), Sell CNTA (55,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | CLARIVATE PLC (CLVT) | Director | Sell | 8,178 | $19,954 |
| 2026-05-15 | CLARIVATE PLC (CLVT) | Director | Buy | 62,264 | $0 |
| 2025-07-21 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Buy | 55,000 | $211,750 |
| 2025-07-21 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 55,000 | $875,600 |
| 2025-06-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 55,000 | $694,650 |
| 2025-06-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Buy | 55,000 | $211,750 |
| 2025-05-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Buy | 55,000 | $211,750 |
| 2025-05-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 55,000 | $699,050 |
| 2025-05-08 | CLARIVATE PLC (CLVT) | Director | Sell | 4,974 | $20,742 |
| 2025-05-08 | CLARIVATE PLC (CLVT) | Director | Buy | 39,473 | $0 |
| 2025-04-22 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 14,656 | $180,122 |
| 2025-04-22 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 40,344 | $501,476 |
| 2025-03-21 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 55,000 | $917,950 |
| 2025-03-05 | CLARIVATE PLC (CLVT) | Director | Buy | 58,275 | $254,079 |
| 2025-02-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 54,225 | $863,262 |
| 2025-02-20 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 775 | $12,818 |
| 2025-02-04 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 43,381 | $734,007 |
| 2025-01-22 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 1,625 | $26,309 |
| 2025-01-22 | Centessa Pharmaceuticals plc (CNTA) | Chief Executive Officer | Sell | 53,375 | $841,190 |
Source: SEC Form 4 filings · as of 2026-05-15